Foghorn Therapeutics Inc.
NASDAQ:FHTX

Watchlist Manager
Foghorn Therapeutics Inc. Logo
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Watchlist
Price: 8.89 USD 0.45% Market Closed
Market Cap: 491.9m USD
Have any thoughts about
Foghorn Therapeutics Inc.?
Write Note

Foghorn Therapeutics Inc.
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Foghorn Therapeutics Inc.
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Cash from Financing Activities
$1.8m
CAGR 3-Years
-80%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$2.8B
CAGR 3-Years
45%
CAGR 5-Years
25%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$6.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-3%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
-$5.3B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$1B
CAGR 3-Years
8%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.5B
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Foghorn Therapeutics Inc.'s Cash from Financing Activities?
Cash from Financing Activities
1.8m USD

Based on the financial report for Dec 31, 2023, Foghorn Therapeutics Inc.'s Cash from Financing Activities amounts to 1.8m USD.

What is Foghorn Therapeutics Inc.'s Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-49%

Over the last year, the Cash from Financing Activities growth was -1%. The average annual Cash from Financing Activities growth rates for Foghorn Therapeutics Inc. have been -80% over the past three years , -49% over the past five years .

Back to Top